Tuesday, April 22, 2025 | 05:12 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch
Sensex (    %)
                             
Nifty (    %)
                             
Nifty Midcap (    %)
                             
Nifty Smallcap (    %)
                             
Nifty Bank (    %)
                             
Home / Markets / Natco Pharma Ltd

Natco Pharma Share Price

Know More
BSENSE

₹784.05-10.95 (-1.38%)

16:01 PM, 12-Mar-2025
Stock not traded

BSE : 524816

NSE : NATCOPHARM

Sector : Health care

ISIN Code : INE987B01026

  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 12-Mar-2025 | 04:01 PM IST

Add to PortfolioAdd to Watchlist

Market Cap (₹ Cr)

14,042

Traded Value (₹ Cr)

5.37

Volume (Shares)

68,478

Face Value (₹)

2

52-Week High (₹)

1,638.35

52-Week High Date

12-Sep-2024

52-Week Low (₹)

660.05

52-Week Low Date

07-Apr-2025

All Time High (₹)

1,638.35

All Time High Date

12-Sep-2024

All Time Low (₹)

1.60

All Time Low Date

17-Sep-2001

Natco Pharma Ltd

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development manufacturing and marketing of Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs). The Company's focus is primarily on niche therapeutic areas and complex products. It sells products in over 40 countrie...
Read More

Natco Pharma Ltd News

Natco launches additional strengths of generic version of Revlimid in US

1 min read

Breather for Natco in Novartis cardiac drug case from Delhi High Court

2 min read

Aegis Vopak Terminals gets Sebi nod to float ₹3,500 crore IPO; key details

3 min read

Gold price dips ₹10 to ₹95,170, silver price falls ₹100 to ₹99,700

2 min read

Stock Market LIVE: Sensex volatile despite 25 bps rate cut by RBI; Trump tariffs in focus

2 min read
More

Natco Pharma Announcement

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Natco Pharma Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24230TG1981PLC003201</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>AA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>ICRA LIMITED</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>NSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: CH VENKAT RAMESH <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: venkatramesh.ch@natcopharma.co.in</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: S V V N APPA RAO <br/> Designation: CHIEF FINANCIAL OFFICER <br/> EmailId: svvn@natcopharma.co.in</div> </div> <div> <br/> Date: 09/04/2025<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>

Legal Update regarding RISDIPLAM launch in India

Announcement under Regulation 30 (LODR) Regulations 2015

Disclosure under regulation 30 of the SEBI (LODR) Regulations 2015

Closure of Trading Window

More

Natco Pharma Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

14,042

EPS - TTM (₹) [C]

104.13

P/E Ratio (X) [C]

7.53

Face Value (₹) 2
Latest Dividend (%)75.00
Latest Dividend Date 18-Feb-2025
Dividend Yield (%) 1.21
Book Value Share (₹) [C]399.19
P/B Ratio (₹) [C]1.96

[*C] Consolidated [*S] Standalone

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
Tata Equity P/E Fund-(IDCW-Trigger-Opt B-10%) 130.40 16,92,000 1.75
Tata Equity P/E Fund - (IDCW-Trigger - Opt A - 5%) 130.40 16,92,000 1.75
Tata Equity P/E Fund - Direct (G) 130.40 16,92,000 1.75
Tata Equity P/E Fund - Dir(IDCW-Trigger-Opt A-5%) 130.40 16,92,000 1.75
Tata Equity P/E Fund - Dir(IDCW-Trigger-Opt B-10%) 130.40 16,92,000 1.75
Tata Equity P/E Fund - (G) 130.40 16,92,000 1.75
Tata Small Cap Fund - Direct (G) 42.32 5,49,064 0.51
Tata Small Cap Fund - Direct (IDCW) RI 42.32 5,49,064 0.51
Tata Small Cap Fund - Regular (IDCW) RI 42.32 5,49,064 0.51
Tata Small Cap Fund - Direct (IDCW) 42.32 5,49,064 0.51

Load more

Research Reports

DateBrokerActionPrices(₹) Report
04-Oct-2024Edelweiss Securities Hold -

Stock Strength

Today's Low/High (₹)

780.05

804.55

Week Low/High (₹)

502.00

804.55

Month Low/High (₹)

502.00

804.55

Year Low/High (₹)

660.05

1,638.00

All time Low/High (₹)

1.60

1,638.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week46.57%46.40%22.97%27.64%
1 Month39.13%39.21%19.03%23.24%
3 Month25.82%25.79%19.93%24.47%
6 Month4.58%4.62%25.04%29.23%
1 Year-14.02%-14.02%24.11%27.96%
3 Year25.51%25.48%82.98%91.93%

Company Info

Company Information

Chairman & Managing Director : V C Nannapaneni

Non-Exec. & Independent Dir. : G S Murthy

Vice Chairman & CEO : Rajeev Nannapaneni

Non-Exec. & Independent Dir. : T V Rao

Non-Exec. & Independent Dir. : D G Prasad

Non-Exec. & Independent Dir. : Leelaa Digumarti

Executive Director : PSRK Prasad

Non-Exec. & Independent Dir. : MUR Naidu

President & Director : D Linga Rao

Registered Office: Natco House, Road No 2 Banjara Hills,Hyderabad,Telangana-500033 Ph: 91-040-23547532

Email:investors@natcopharma.co.in

URL:http://www.natcopharma.co.in

FAQs about Natco Pharma Ltd

1. What's the Natco Pharma Ltd share price today?
Natco Pharma Ltd share price was Rs 784.05 at 16:01 PM IST on 12th Mar 2025. Natco Pharma Ltd share price was down by 1.38% from the previous closing price of Rs 795.00. Natco Pharma Ltd share price trend:

  • Last 1 Month: Natco Pharma Ltd share price moved up by 39.13% on BSE.
  • Last 3 Months: Natco Pharma Ltd share price moved up by 25.82% on BSE.
  • Last 12 Months: Natco Pharma Ltd share price moved down by 14.02% on BSE.
  • Last 3 Years: Natco Pharma Ltd share price moved up by 25.51% on BSE.


2. How can I quickly analyse the performance of the Natco Pharma Ltd stock?
The performance of the Natco Pharma Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 7.53
  • Price to book value ratio is 1.96
  • Dividend yield of 1.21
  • The EPS (trailing 12 months) of the Natco Pharma Ltd stock is Rs 104.13


3. What is the market cap of Natco Pharma Ltd?
Natco Pharma Ltd has a market capitalisation of Rs 14,042 crore.


4. What is Natco Pharma Ltd's 52-week high/low share price?
The Natco Pharma Ltd’s 52-week high share price is Rs 1,638.35 and 52-week low share price is Rs 660.05.


5. Is the Natco Pharma Ltd profitable?
On a consolidated basis, Natco Pharma Ltd reported a profit of Rs 132.40 crore on a total income of Rs 651.10 crore for the quarter ended 2024. For the year ended 2024, Natco Pharma Ltd had posted a profit of Rs 1,388.30 crore on a total income of Rs 3,998.80 crore.


6. Which are Natco Pharma Ltd’s peers in the Health care sector?
Natco Pharma Ltd’s top 5 peers in the Health care sector are Sai Life, Neuland Labs., Caplin Point Lab, Natco Pharma, Jubilant Pharmo, Sanofi India, Alivus Life.


7. Who owns how much in Natco Pharma Ltd?
Key changes to the Natco Pharma Ltd shareholding are as follows:

  • Promoter holding in Natco Pharma Ltd has gone up to 48.82 per cent as of Dec 2022 from 48.81 per cent as of Mar 2022.

HOT STOCKS
TOP SECTIONS
KEY EVENTS
Copyrights © 2025 Business Standard Private Ltd. All rights reserved
LinkedIN Icon